Skip to NavigationSkip to content

Industry lobbies ministers ahead of OFT decision

Published on 01/05/07 at 11:58am

The UK pharmaceutical industry is using a series of meetings with government ministers to push for a rejection of the OFT report on medicines prices.

Industry association the ABPI has made it clear that it opposes the reforms put forward by competition watchdog the Office of Fair Trading, which involves scrapping the current PPRS pricing system.

Last week, health secretary Patricia Hewitt and health minister Lord Hunt met the ABPI leaders as part of extensive negotiations ahead of a government decision expected in June.

Gordon Brown's treasury department is also heavily involved in discussions, as is the Department of Trade and Industry, which is responsible for delivering the final decision.

Addressing the annual ABPI dinner last week, health minister Lord Hunt revealed he had also recently toured the boardrooms of the top pharmaceutical companies in the US, and had discussed the OFT report, NICE and other key UK market issues.

Hunt stressed that no decisions had been made on the OFT report, but pledged to keep working in collaboration with the industry.

These comments, added to hints from Blair in March, make it highly unlikely the OFT report will be accepted in its present form  but the terms of any compromise deal remain far from clear.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches